-
Trends and Economic Impact of Medication Errors in Public Hospitals of Eastern Region Ghana: A Retrospective Analysis From 2018 to 2024
Sep 9, 2025, 16:22 PM -
Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?
Sep 9, 2025, 16:22 PM -
The Effect of Nutritional Supplements on Semen Quality and Pregnancy Rates in Patients With Male Factor Infertility: A Systematic Literature Review and Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review
Sep 9, 2025, 16:22 PM -
NICE National Institute for Health and Care Excellence Highly Specialized Technology Evaluations: Use of Pivotal Clinical Trial Outcomes to Inform Relative Treatment Effect and Utilities
Sep 9, 2025, 16:22 PM -
Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System
Sep 9, 2025, 16:22 PM -
The Impact of the COVID-19 Pandemic on the Performance of the Hospital Care System in Romania as Measured Using the Diagnosis-Related Groups (DRGs) Financing Technique
Sep 9, 2025, 16:22 PM -
Effectiveness of Vonoprazan on Health-Related Quality of Life and Sleep Quality in Chinese Patients With Reflux Esophagitis: Post Hoc Analysis of the VIEW Study
Sep 9, 2025, 16:22 PM -
Navigating the Transition: What EU JCA Means for AMNOG Submissions in 2025 and Beyond
Sep 9, 2025, 16:22 PM -
Analysis of Clinical and Economic Evidence Focused on RWE in Medicare Drug Price Negotiations: Sacubitril/Valsartan, Rivaroxaban, and Apixaban
Sep 9, 2025, 16:22 PM -
From Development to Reimbursement Evidence-Generation Strategies for HealthTech in Europe
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact of High-Dose Trivalent Influenza Vaccine Efluelda® in Older Adults: A Greek Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Shifts in Medicine Reimbursement in Türkiye: Who Pays for Medicines (2015-2022)?
Sep 9, 2025, 16:22 PM -
Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis
Sep 9, 2025, 16:22 PM -
A Review of Approaches to Select Instruments and Items to Measure Patient Reported Tolerability in Clinical Trials in Oncology
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of LGI-Flag in Austria: A Model-Based Evaluation
Sep 9, 2025, 16:22 PM -
Advancing Target Trial Emulation With Synthetic Data: The Target Trial Optimization Framework
Sep 9, 2025, 16:22 PM -
Treatment Effect Extrapolation Assumptions in NICE Highly Specialized Technology Appraisals
Sep 9, 2025, 16:22 PM -
Accessibility and Time to Reimbursement of Treatments With Substantial Benefit: A Comparative Analysis Focused on Inequalities Between Different European Countries and Different Tumor Types
Sep 9, 2025, 16:22 PM -
Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework
Sep 9, 2025, 16:22 PM
